Skip to main content
. 2022 Jun 30;11(6):2816–2823. doi: 10.4103/jfmpc.jfmpc_2274_21

Table 3.

Distribution of participants by age group and type of study site

Age group Location

Urban Rural


Total participants (n) Total seropositive (n) Adjusted prevalence (%) 95% CI Total participants (n) Total seropositive (n) Adjusted prevalence (%) 95% CI
<18 years 92 68 (73.9) (63.7-82.5) 78.3 (69.8-86.7) 608 322 (52.9) (49.0-56.9) 55.9 (52.0-59.9)
≥18 years 909 680 (74.8) (71.8-77.6) 79.2 (76.6-81.8) 2900 1741 (60.0) (58.3-61.8) 63.5 (61.8-65.3)
Total 1001 748 (74.7) (71.9-77.4) 79.1 (76.5-81.6) 3508 2063 (58.8) (57.2-60.4) 62.2 (60.7-63.9)

CI=confidence interval